As depicted in Figure 2B, a progressive increase in Gal-3 expression is observed in adenoma and during the progression toward advanced cancer, with changes in its subcellular localization from the nucleus in adenomas to cytoplasm in CRC. Here, LGALS3 is linked to cancer.